Hexagon Capital Partners LLC Has $53,000 Position in The Clorox Company (NYSE:CLX)
Hexagon Capital Partners LLC Has $53,000 Position in The Clorox Company (NYSE:CLX)
Hexagon Capital Partners LLC reduced its holdings in The Clorox Company (NYSE:CLX – Get Rating) by 22.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 381 shares of the company's stock after selling 109 shares during the quarter. Hexagon Capital Partners LLC's holdings in Clorox were worth $53,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. grew its position in shares of Clorox by 1.3% in the first quarter. Vanguard Group Inc. now owns 14,685,046 shares of the company's stock valued at $2,041,661,000 after purchasing an additional 185,012 shares during the last quarter. BlackRock Inc. lifted its stake in shares of Clorox by 5.6% in the third quarter. BlackRock Inc. now owns 10,964,049 shares of the company's stock valued at $1,407,673,000 after buying an additional 580,982 shares during the period. State Street Corp lifted its stake in shares of Clorox by 9.6% in the second quarter. State Street Corp now owns 8,907,083 shares of the company's stock valued at $1,255,721,000 after buying an additional 778,269 shares during the period. Wells Fargo & Company MN lifted its stake in shares of Clorox by 2.4% in the second quarter. Wells Fargo & Company MN now owns 3,557,161 shares of the company's stock valued at $501,489,000 after buying an additional 82,698 shares during the period. Finally, Federated Hermes Inc. lifted its stake in shares of Clorox by 11.1% in the third quarter. Federated Hermes Inc. now owns 2,161,323 shares of the company's stock valued at $277,492,000 after buying an additional 215,425 shares during the period. 79.12% of the stock is owned by institutional investors and hedge funds.
Get Clorox alerts:Clorox Stock Performance
NYSE CLX opened at $154.61 on Friday. The firm has a market cap of $19.10 billion, a price-to-earnings ratio of 44.17, a PEG ratio of 3.16 and a beta of 0.29. The company has a 50 day moving average of $150.33 and a 200-day moving average of $144.84. The company has a current ratio of 0.86, a quick ratio of 0.47 and a debt-to-equity ratio of 5.04. The Clorox Company has a 1-year low of $120.50 and a 1-year high of $160.59.
Clorox (NYSE:CLX – Get Rating) last posted its quarterly earnings data on Thursday, February 2nd. The company reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.66 by $0.32. The company had revenue of $1.72 billion during the quarter, compared to analyst estimates of $1.66 billion. Clorox had a net margin of 6.16% and a return on equity of 89.97%. The company's revenue was up 1.4% on a year-over-year basis. During the same quarter last year, the business posted $0.66 earnings per share. On average, equities analysts forecast that The Clorox Company will post 4.23 earnings per share for the current fiscal year.
Clorox Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, May 12th. Investors of record on Wednesday, April 26th will be issued a $1.18 dividend. This represents a $4.72 dividend on an annualized basis and a dividend yield of 3.05%. The ex-dividend date of this dividend is Tuesday, April 25th. Clorox's dividend payout ratio is currently 134.86%.
Analyst Ratings Changes
Several equities research analysts recently weighed in on the stock. StockNews.com assumed coverage on shares of Clorox in a research note on Thursday, March 16th. They issued a "hold" rating for the company. Morgan Stanley increased their target price on shares of Clorox from $142.00 to $145.00 and gave the company an "equal weight" rating in a research note on Friday, February 3rd. Barclays reduced their target price on shares of Clorox from $110.00 to $108.00 and set an "underweight" rating for the company in a research note on Monday, February 6th. Jefferies Financial Group raised their price target on shares of Clorox from $140.00 to $145.00 and gave the stock a "hold" rating in a research note on Wednesday, February 1st. Finally, Deutsche Bank Aktiengesellschaft cut their price target on shares of Clorox from $152.00 to $147.00 in a research note on Monday. Seven equities research analysts have rated the stock with a sell rating, six have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, Clorox currently has a consensus rating of "Hold" and a consensus price target of $141.00.
Clorox Company Profile
(Get Rating)
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.
Recommended Stories
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- KB Home Strong Results Lift Prices
- Chewy Stock Is Setting Up For Long-Term Profitable Growth
- Why Wall Street Loves These 3 Penny Stocks
- Carvana May Be Able To Reach Profitability This Year
- Low Volume Bunge Plunge Presents an Opportunity
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
據高樂氏最近向美國證券交易委員會披露的消息,六角大樓資本合夥公司在第四季度減持了高樂氏22.2%的股份。該基金在本季度出售了109股後,持有該公司381股股票。截至最近向美國證券交易委員會提交的檔案,Hexagon Capital Partners LLC持有的高樂氏股份價值53,000美元。
其他幾家對沖基金和其他機構投資者最近也調整了他們在該業務中的頭寸。先鋒集團(Vanguard Group Inc.)第一季度增持了1.3%的高樂氏股票。先鋒集團目前持有14,685,046股該公司股票,價值2,041,661,000美元,上一季度又購買了185,012股。貝萊德股份有限公司在第三季度增持了高樂氏5.6%的股份。貝萊德股份有限公司在此期間又購買了580,982股,目前持有該公司10,964,049股股票,價值1,407,673,000美元。道富銀行在第二季度增持了9.6%的高樂氏股票。道富銀行目前持有8,907,083股該公司股票,價值1,255,721,000美元,在此期間又購買了778,269股。富國銀行MN在第二季度增持了2.4%的高樂氏股票。Wells Fargo&Company MN在此期間額外購買了82,698股,現在擁有3,557,161股該公司股票,價值501,489,000美元。最後,聯合愛馬仕公司在第三季度增持了高樂氏11.1%的股份。聯合愛馬仕公司目前持有該公司2,161,323股股票,價值277,492,000美元,在此期間又購買了215,425股。79.12%的股票由機構投資者和對沖基金持有。
到達高樂氏警報:高樂氏股票表現
紐約證交所CLX上週五開盤報154.61美元。該公司市值為191億美元,本益比為44.17倍,本益比為3.16倍,貝塔係數為0.29。該公司的50日移動均線切入位在150.33美元,200日移動均線切入位在144.84美元。該公司的流動比率為0.86,速動比率為0.47,債務權益比率為5.04。高樂氏公司的一年低點為120.50美元,一年高位為160.59美元。
高樂氏(紐約證券交易所代碼:CLX-GET Rating)最近一次公佈季度收益數據是在2月2日星期四。該公司公佈本季度每股收益為0.98美元,比普遍預期的0.66美元高出0.32美元。該公司本季度營收為17.2億美元,而分析師預期為16.6億美元。高樂氏的淨利潤率為6.16%,股本回報率為89.97%。該公司的收入同比增長了1.4%。去年同一季度,該公司公佈的每股收益為0.66美元。股票分析師平均預測,高樂氏公司本財年的每股收益將達到4.23歐元。
高樂氏宣佈分紅
該業務最近還宣佈了季度股息,將於5月12日(星期五)支付。4月26日(星期三)登記在冊的投資者將獲得1.18美元的股息。這意味著年化股息為4.72美元,股息收益率為3.05%。本次股息除息日期為4月25日(星期二)。高樂氏的股息支付率目前為134.86。
分析師評級發生變化
幾位股票研究分析師最近對該股進行了加碼。斯托克新聞網在3月16日星期四的一份研究報告中對高樂氏的股票進行了報道。他們對該公司的評級為“持有”。摩根士丹利在2月3日星期五的一份研究報告中將高樂氏股票的目標價從142.00美元上調至145.00美元,並給予該公司“同等權重”的評級。巴克萊將高樂氏股票的目標價從110.00美元下調至108.00美元,並在2月6日週一的一份研究報告中對該公司設定了“減持”評級。2月1日週三,傑富瑞金融集團將高樂氏股票的目標價從140.00美元上調至145.00美元,並在一份研究報告中給出了該股“持有”的評級。最後,德意志銀行Aktiengesellschaft在週一的一份研究報告中將高樂氏的目標價從152.00美元下調至147.00美元。7名股票研究分析師將該股評級為賣出,6名分析師給予持有評級,一名分析師給予該股買入評級。根據MarketBeat的數據,高樂氏目前的共識評級為持有,共識目標價為141.00美元。
高樂氏公司簡介
(獲取評級)
高樂氏公司從事消費品和專業產品的製造和營銷。它通過以下業務部門運營:健康和健康、家庭、生活方式和國際。健康和健康部分包括清潔產品、專業產品和維生素、礦物質和補充劑,主要在美國銷售和銷售。
推薦故事
- 免費獲取StockNews.com關於高樂氏的研究報告
- KB Home強勁業績提振價格
- 咀嚼股票正在為長期盈利增長做準備
- 華爾街為什麼喜歡這3便士股票
- Carvana今年可能實現盈利
- 低成交量捆綁暴跌帶來機遇
接受《高樂氏日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Clorox和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧